ICC Labs
About ICC Labs
ICC Labs is a Uruguayan cannabis company acquired by Tilray. It was one of the first licensed producers in Uruguay and serves both the domestic and international markets.
Key Facts
- 1Acquired by Tilray/Aphria making it part of a global cannabis company
- 2One of Uruguay's first licensed commercial cannabis producers
Latest News
Cannabis Stocks Rally as DEA Moves Marijuana to Schedule III
AKAN surges alongside TLRY and CGC as federal rescheduling triggers sector-wide momentum with June 2026 hearing set to finalize broader cannabis reclassification.
Major Cannabis Stocks Plunge on Rescheduling Reality Check
TLRY, CGC, ACB, CRON, and OGI tumble as investors reassess limited impact of federal cannabis reclassification on Canadian operators and market fundamentals.
Cannabis Stocks Plunge as Rescheduling Optimism Fades
Major cannabis operators including TLRY, CGC, and ACB tumble as investors reassess limited impact from federal reclassification prospects.
TLRY Stock Plunges 19% as Cannabis Sector Faces Mounting Pressure
Tilray Brands shares tumble amid broader cannabis market selloff, raising questions about sector fundamentals and investor appetite for marijuana stocks.
Cannabis Stocks Whipsaw on Federal Rescheduling Uncertainty
TLRY and cannabis equities experience volatile trading as investors parse mixed signals on federal marijuana policy changes and regulatory timeline.
Frequently Asked Questions
Who owns ICC Labs?
ICC Labs was acquired by Aphria (now Tilray) and operates as part of Tilray's Latin American operations.
What products does ICC Labs produce?
ICC Labs produces cannabis flowers for the Uruguayan market and hemp-derived CBD products for export.
More Cannabis Companies in Montevideo
Products
- Cannabis flowers
- Hemp CBD products
- Cannabis extracts
Specialties
Company Details
- Location
- Montevideo, Uruguay
- Founded
- 2017
- Publicly Traded
- Yes
- Ticker
- NASDAQ:TLRY